NCT-501 hydrochloride is a potent and selective inhibitor of aldehyde dehydrogenase 1A1 (ALDH1A1), with an IC50 of 40 nM against hALDH1A1 and high selectivity over other ALDH isoforms and dehydrogenases (IC50 > 57 μM for hALDH1B1, hALDH3A1, and hALDH2); it demonstrates antitumor activity by inhibiting tumor growth by 78% in Cal-27 CisR-derived xenografts when administered intrathecally at 100 µg per animal every other day for 20 days.